A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) who have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event ACCLAIM-Lp

15493J3L-MC-EZEFOpenA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) who have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event ACCLAIM-LpNCT06292013IndustrialAdultTreatmentAtherosclerotic heart diseasePark, JeanMedStar Community Clinical Research Center : Maria Hurtado; MedStar Community Clinical Research Center - Hyattsville : Maria Hurtado; MedStar Medical Group - Hyattsville Clinic : Maria HurtadoMHRI Community Research7043Maria HurtadoMaria HurtadoMaria.E.Hurtado@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>